DUBLIN–(BUSINESS WIRE)–The “Polymerase Chain Reaction (PCR) Technologies and Global Markets 2021-2026” report has been added to ResearchAndMarkets.com’s offering.
The global market for PCR technology should grow from $10.5 billion in 2021 to $13.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
The reagents and consumables market for PCR technology should grow from $6.3 billion in 2021 to $8.4 million by 2026, at a CAGR of 6.0% for the period of 2021-2026.
The software market for PCR technology should grow from $590.8 million in 2021 to $776.1 million by 2026, at a CAGR of 5.6% for the period of 2021-2026.
This report examines the market potential of PCR technology. It offers a detailed analysis of the competitive environment, regulatory scenario, technological advances, drivers and restraints, and opportunity and trends in market growth. The report also covers market projections to 2026 and market rankings for key players. The report discusses the market share of PCR technologies based on type of product, technology and application.
This report segments the global market by four geographical regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW). For the purpose of this report, North America includes the U.S., Canada and Mexico; the European region includes Germany, U.K., France and Rest of Europe; the Asia-Pacific region includes China, India, Japan, and the Rest of Asia-Pacific; and RoW includes the Middle East, Africa and South America. For market estimates, data is provided for the year 2020 as the base year, 2019 as the historical year and forecasts are through year-end 2026.
Companies Mentioned
Abbott Laboratories Agilent Technologies Inc. Becton, Dickinson And Co. Bio-Rad Laboratories Inc. Biofire Diagnostics Llc Bioneer Corp. Eppendorf Ag F. Hoffmann-La Roche Ltd. Qiagen Nv Thermo Fisher Scientific Inc. Report Includes
70 data tables and 15 additional tables An updated review of the global market for polymerase chain reaction (PCR) technologies Analyses of the global market trends, with data from 2019-2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026 Discussion of major factors driving the growth of the PCR market, industry structure, regulatory scenario, and penetration of technologies in molecular diagnosis of infectious diseases Estimation of market size and revenue sales forecast for PCR products, and corresponding market share analysis by product, technology type, application, and geographic region Impact of the COVID-19 on the market for PCR technology, R&D efforts and the need to reinvent medical ventilators, current status and impact on Medtech Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for PCR technology in clinical diagnostics Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages Competitive landscape of the major players operating in the global market, their competitive environment and product portfolio analysis Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Background and Technology Overview
Evolution of PCR Principles of PCR Instruments and Components of PCR Instruments Target DNA Primers Enzyme and Enzyme Concentration Buffers Magnesium Concentration Deoxyribonucleoside Triphosphates Types of PCR Reverse Transcription PCR Nested PCR Hot Start and Touchdown PCR Inverse PCR Multiplex PCR Quantitative PCR Traditional vs. Real-Time PCR Design of Primer for PCR Primer Selection Primer Length Melting Temperature Specificity G/C Content 3′ End Sequence PCR Quantification Methods Absolute Quantification Relative Quantification Components of Quantitative PCR DNA Binding Dyes Probes in qPCR Controls for qPCR Experiments Chapter 4 COVID-19 and R&D
Potential Targets for COVID-19 Drug Development Basigin (CD147) C-C Chemokine Receptor Type 5 (CCR5) Envelope Protein (E) (SARS-CoV-2; COVID-19) Epithelial Sodium Channel (ENaC) Histamine N-Methyltransferase (HMT) Interleukin-6 Receptor Subunit ? (IL-6RA) Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19) Nucleocapsid (N) (SARS-CoV-2; COVID-19) R&D on COVID-19 COVID-19 Clinical Trial Landscape Chapter 5 Regulatory Structure of the COVID-19 Diagnostics Industry
Coronavirus Treatment Acceleration Program (CTAP) Clinical Trials being Conducted during COVID-19 Pandemic Response to Drug Shortages National Regulatory Agencies for Ongoing Clinical Trials U.S. FDA Medicines and Healthcare Products Regulatory Agency (U.K.) European Medicines Agency COVID-19 Testing Chapter 6 Polymerase Chain Reaction: Market Dynamics
Market Dynamics Market Drivers Market Restraints Market Opportunities Chapter 7 Impact of COVID-19 Pandemic
Outbreak Progression of COVID-19 Incubation Period Epidemiology Collaboration Between Organizations and Governments Spread of Disease Current Status and Impact on Medical Technology Elective and Noncritical Procedures Shift in Manufacturing Delays of Clinical Trials Supply Chain Disruptions Medical Tourism Chapter 8 Market Breakdown by Product Type
Chapter 9 Market Breakdown by Technology
Chapter 10 Market Breakdown by Application
Chapter 11 Market Breakdown by Region
Chapter 12 Competitive Landscape
Chapter 13 Company Profiles
Chapter 14 Appendix: List of Abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/47exg5